Crescita Therapeutics Touts Record Revenue, EBITDA For Fiscal 2019

Crescita Therapeutics Inc. (TSX: CTX) (OTC: CRRTF), a Canadian dermatology company that researches and develops cannabis ;disclosed Wednesday its fourth quarter and fiscal 2019 financial results.

The Mississauga-based company reported annual record revenue of CA$22.34 million ($15.52 million), up by 34.3% from the previous year. Quarterly revenue of CA$3.82 million was down by 38.4% from the same period in the prior year.

In fiscal 2019, Crescita reached a record …

Full story available on Benzinga.com

More Crescita Therapeutics Touts Record Revenue, EBITDA For Fiscal 2019